1401, University of Washington Positive Research CRS
1401, University of Washington Positive Research CRS
Seattle, Washington, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission | Acute HIV Infection | Recruiting | Phase 2 | 2026-08-18 | NCT05719441 | |
| Dasatinib for HIV-1 Reservoir Reduction | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 1 | 2026-08-04 | NCT07342491 |